Filing Details
- Accession Number:
- 0001022079-24-000168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-26 18:33:35
- Reporting Period:
- 2024-07-24
- Accepted Time:
- 2024-07-26 18:33:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1955265 | E Mark Delaney | 500 Plaza Drive C/O Quest Diagnostics Inc Secaucus NJ 07094 | Svp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-22 | 6 | $146.98 | 5,439 | No | 5 | L | Direct | |
| Common Stock | Disposition | 2024-07-24 | 420 | $143.08 | 5,019 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | L | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Billionaire Hedge Funds
